Young H. Rho
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Biosimilar SB17 versus reference ustekinumab in moderate to severe plaque psoriasis after switching: phase 3 study results up to week 52.
Journal: The Journal of dermatological treatment
Published: December 10, 2024
SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial.
Journal: Bone
Published: October 28, 2024
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 03, 2024
A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis.
Journal: Journal of the American Academy of Dermatology
Published: January 26, 2024
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study.
Journal: Annals of the rheumatic diseases
Published: May 05, 2017
Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results.
Journal: Rheumatology (Oxford, England)
Published: December 13, 2016
Difference between SB4 and reference etanercept in the hepatobiliary disorders not considered to be caused by SB4: response to letter by Scheinberg and Azevedo.
Journal: Annals of the rheumatic diseases
Published: July 20, 2016
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
Journal: Annals of the rheumatic diseases
Published: April 10, 2015
Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.
Journal: Clinical rheumatology
Published: October 10, 2014
Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.
Journal: Annals of the rheumatic diseases
Published: April 29, 2014
Allopurinol initiation and all-cause mortality in the general population.
Journal: Annals of the rheumatic diseases
Published: January 21, 2014
Last Updated: 09/26/2026